Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin in Primary Intracerebral Hemorrhage
NCT06899464Phase 4Not yet recruiting
- Sponsor
- Cardinal Stefan Wyszyński University in Warsaw
- Start
- Oct 2025
- Primary completion
- Jan 2027
- Modality
- Native Peptides
01
Overview
A Phase 4 trial of cerebrolysin in intracerebral hemorrhage (ICH), sponsored by Cardinal Stefan Wyszyński University in Warsaw. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
cerebrolysin
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT06899464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06899464.